| (Values in U.S. Thousands) | Jun, 2023 | Jun, 2025 | Dec, 2024 | Jun, 2024 | Dec, 2023 |
| Sales | 28,080 | 31,250 | 32,830 | 28,640 | 29,380 |
| Sales Growth | -10.14% | -4.81% | +14.63% | -2.52% | +1.80% |
| Net Income | 1,340 | 60 | 2,350 | 2,140 | 4,670 |
| Net Income Growth | +2,133.34% | -97.45% | +9.81% | -54.18% | +11.46% |
Intercure Ltd (INCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK.
Fiscal Year End Date: 12/31